Filter
471
Filtered Results: 471
Text search:
International
Pharmaceutical
Federation
Featured
Recommendations
47
New Publications
111
Language
Document type
No document type
241
Studies & Reports
95
Guidelines
67
Manuals
25
Strategic & Response Plan
20
Training Material
13
Fact sheets
5
Situation Updates
2
Resource Platforms
2
Brochures
1
Countries / Regions
Global
27
India
21
Western and Central Europe
18
Nigeria
16
Ukraine
13
Kenya
10
South Africa
9
Eastern Europe
8
Ethiopia
6
Nepal
6
Syria
6
Africa
6
Eastern Europe and Central Asia
5
Sierra Leone
4
Uganda
4
Germany
4
Latin America and the Carribbean
4
Russia
4
Liberia
3
Cameroon
3
Brazil
3
Lesotho
3
Myanmar / Burma
3
Asia
3
Senegal
2
Congo, Democratic Republic of
2
Zimbabwe
2
Philippines
2
South Sudan
2
Tanzania
2
Rwanda
2
Bangladesh
2
Namibia
2
North Macedonia
2
Venezuela
2
Moldova
2
Kyrgyzstan
2
Guinea
1
Mali
1
Ghana
1
Niger
1
Haiti
1
Iraq
1
Jordan
1
Zambia
1
Chad
1
Indonesia
1
Malawi
1
Serbia
1
Ecuador
1
Botswana
1
Yemen
1
South–East Asia Region
1
Albania
1
Armenia
1
Laos
1
Tajikistan
1
Bulgaria
1
Uzbekistan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
124
Clinical Guidelines
43
Public Health
27
Key Resources
23
Women & Child Health
16
Capacity Building
10
Pharmacy & Technologies
9
Toolboxes
Mental Health
37
AMR
37
TB
36
COVID-19
36
HIV
34
Pharmacy
34
NCDs
21
Conflict
18
Rapid Response
18
Caregiver
11
Global Health Education
10
Planetary Health
9
Ebola
6
Refugee
6
NTDs
6
Health Financing Toolbox
6
Specific Hazards
5
Natural Hazards
4
Disability
3
Polio
3
Zika
1
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
Accessed on 31.03.2020
This Guidance Note aims to provide humanitarian child protection practitioners, particularly child protection advisors and program managers, with guidance on how to engage in responses to infectious disease outbreaks to ensure children’s protection needs are taken into ac...
Effective antibiotics are essential for childrens’ survival
This inter-agency guidance document aims to supplement the COVAX demand creation package for COVID-19 vaccines with key considerations for humanitarian contexts and marginalized populations with specific access and communication needs.
21 Sept.2021
This report assesses the impact of the conflict in Ukraine and its implications for organized crime and security-related issues for neighbouring countries, with a focus on Moldova.
These include:
Organized crime and illicit trafficking (including trafficking in persons, drugs, arms, illicit toba...
J of Pharm Policy and Pract 14, 27 (2021). https://doi.org/10.1186/s40545-021-00309-8
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting, ...
Manuel de référence pour les accoucheurs qualifiés
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
16-17 march 2015, Geneva, Switzerland
Meeting report
A guide for effective aid
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
